Use of a heparinoid in patients with hemorrhagic stroke and thromboembolic disease

H. ten Cate; C. P. Henny; H. R. Büller; J. W. ten Cate; H. N. Magnani

Use of a heparinoid in patients with hemorrhagic stroke and thromboembolic disease

H. ten Cate, C. P. Henny, H. R. Büller, J. W. ten Cate, H. N. Magnani

Other Departments

Research output: Contribution to journal › Article › Academic › peer-review

26 Citations (Scopus)

Abstract

A new heparinoid, Org 10172, was given to five patients with hemorrhagic stroke with thromboembolic complications. Treatment did not cause progression of cerebral bleeding, and thrombotic processes were inhibited. No side effects were encountered

Original language	English
Pages (from-to)	268-270
Journal	Annals of neurology
Volume	15
Issue number	3
Publication status	Published - 1984

Cite this

@article{c013341713264d46b45e194182e64835,

title = "Use of a heparinoid in patients with hemorrhagic stroke and thromboembolic disease",

abstract = "A new heparinoid, Org 10172, was given to five patients with hemorrhagic stroke with thromboembolic complications. Treatment did not cause progression of cerebral bleeding, and thrombotic processes were inhibited. No side effects were encountered",

author = "{ten Cate}, H. and Henny, {C. P.} and B{\"u}ller, {H. R.} and {ten Cate}, {J. W.} and Magnani, {H. N.}",

year = "1984",

language = "English",

volume = "15",

pages = "268--270",

journal = "Annals of neurology",

issn = "0364-5134",

publisher = "John Wiley and Sons Inc.",

number = "3",

}

TY - JOUR

T1 - Use of a heparinoid in patients with hemorrhagic stroke and thromboembolic disease

AU - ten Cate, H.

AU - Henny, C. P.

AU - Büller, H. R.

AU - ten Cate, J. W.

AU - Magnani, H. N.

PY - 1984

Y1 - 1984

N2 - A new heparinoid, Org 10172, was given to five patients with hemorrhagic stroke with thromboembolic complications. Treatment did not cause progression of cerebral bleeding, and thrombotic processes were inhibited. No side effects were encountered

AB - A new heparinoid, Org 10172, was given to five patients with hemorrhagic stroke with thromboembolic complications. Treatment did not cause progression of cerebral bleeding, and thrombotic processes were inhibited. No side effects were encountered

M3 - Article

C2 - 6721448

SN - 0364-5134

VL - 15

SP - 268

EP - 270

JO - Annals of neurology

JF - Annals of neurology

IS - 3

ER -